Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Carmike Cinemas Prices $210 Mln Of Senior Notes

RELATED NEWS
Trade CKEC now with 

Carmike Cinemas, Inc. (CKEC: Quote) said Friday that it has priced its unregistered offering of $210 million aggregate principal amount of 7.375% Senior Secured Notes Due 2019.

The notes were priced at par and will bear an interest rate of 7.375% per annum payable semi-annually on May 15 and November 15, beginning on November 15, 2012.

Carmike expects to close the offering of the notes on or about April 27.

Carmike also expects to enter into a new $25 million senior secured revolving credit facility to replace its existing revolving credit facility. Carmike expects the new credit facility to remain undrawn at closing.

The net proceeds from the offering will be used to retire Carmike's existing term loan and to pay related fees and expenses, and any remaining net proceeds will be used for working capital and other general corporate purposes.

Click here to receive FREE breaking news email alerts for Carmike Cinemas Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks showed a significant recovery over the course of the trading day on Monday after coming under pressure in early trading. The markets eventually ended the session roughly flat following the mixed performance that was seen last week. House and Senate negotiators revealed Monday that they have reached an agreement on compromise legislation to reform the scandal-plagued Veterans Affairs Department. After reporting a sharp jump in U.S. pending home sales in the previous month, the National Association of Realtors released a report on Monday showing that pending home sales unexpectedly saw a notable pullback in the month of June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.